Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 30 2023 - 8:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For
the month of May, 2023
Commission
File Number: 001-41106
Incannex
Healthcare Limited
(Exact
name of Registrant as specified in its charter)
not
applicable
(Translation
of Registrant’s name into English)
Australia
(Jurisdiction
of incorporation or organization)
Joel
Latham
Chief
Executive Officer and Managing Director
Level
39, Rialto South Tower
525 Collins Street
Melbourne
3000
Australia
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☒
INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K
On
May 30, 2023, Incannex Healthcare Limited filed with the Australian Securities Exchange an announcement captioned “International
Psychedelics Experts Join Clarion Clinics”, a copy of which announcement is attached to this Form 6-K as Exhibit 99.1.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Incannex Healthcare Limited |
|
|
|
Date: May 30, 2023 |
By: |
/s/ Joel Latham |
|
Name: |
Joel Latham |
|
Title: |
Chief Executive Officer and Managing Director |
INDEX
TO EXHIBITS
3
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Apr 2023 to Apr 2024